Chapter 330 They are not worthy!

When Joffrey started his remarks, he directly named Chen Nan, without any evasion at all.

However, his words did not offend the people around him too much, and many people even laughed.

"hehe……"

"Hahaha……"

These laughters also did not shy away from Chen Nan.

It seems that, as Joffrey said, the gap between the two is too big, and many people do not believe that China has developed a drug that is comparable to car-t cell therapy.

After all, no matter how many changes in oncology drugs have been made over the years, it seems that they have become a game for these large pharmaceutical companies.

Cancer has also become a stage for everyone to compete with each other.

In contrast, China has been weak in this field for a long time, and this is by no means a fact that can be changed overnight.

People like Qin Shiming in the medical field work hard to negotiate with these companies every day.

Keep prices as low as possible to benefit domestic patients.

It seems...China is lagging far behind in this field compared to India, where generic drugs are prevalent.

actually!

Not so. Why doesn't Qin Shiming understand that he can learn from India and liberalize drug patents?

However, if we let go, we will face a very serious problem: bad money chases good money!

When everyone blindly makes imitation drugs and pirated drugs, this is definitely digging their own grave.

Because this means that the benefits of innovation are too low, and no one will work hard in this industry.

The pharmaceutical industry is definitely not like this.

Therefore, many things must be done by oneself even if it is gritted teeth.

Offstage!

Joffrey's words stung the hearts of many people, especially Yuan Chaomin and others.

In everyone's eyes, what Joffrey was mocking was not Chen Nan, but their country!

While overseas, each of them represents that flag and that country.

However, although what Joffrey said was very annoying, how could everyone not understand that this was the current truth?

Being backward is indeed the current situation.

Yuan Chaomin and others took a deep breath, their faces solemn, and their eyes full of determination and a heavy sense of responsibility.

Lu Shouyue glanced at Chen Nan: "Don't worry!"

"We always have to have someone take the first step!"

Chen Nan nodded. Wasn't that what he was feeling?

at this time!

Joffrey stood on the stage, high-spirited.

Car-T cell therapy is indeed a very top therapy in the field of tumor treatment.

It was born in the context of precision medicine. With the help of genetic testing, precise sequencing and other methods, Gilead overtook the company and became one of the top ten anti-cancer drug companies.

Joffrey smiled and said:

"Improvements in CAR-T cell therapy will not only target cells that have already caused cancer."

"We will strengthen T-cell therapy and develop better early anti-cancer drugs."

"Previously, our CAR-T cell therapy was mainly a survival-prolonging therapy for late-stage cancer."

"but!"

"Now, it's different."

"Our new drug will be combined with the NMPA testing company to establish an early intervention cancer program."

"The purpose of early intervention is to allow the body's immune cells to identify those cells that have lost the control of tumor suppressor genes as early as possible, so as to prevent the disease as early as possible!"

…

Following Joffrey's excited words, the scene was plunged into crazy discussions.

Chen Nan was also a little surprised. Sure enough, the background and technological strength of these large pharmaceutical companies are indeed beyond what we can currently catch up with.

The other party's plan was actually similar to what I had in mind.

I have to say, it’s true that we are enemies on the same road.

The core of the other party's improved car-t cell therapy lies in early intervention and early treatment.

By cultivating special immune cells in vitro, cells with early loss of tumor suppressor genes can be cleaned up!

This is obviously an idea of ​​not treating the existing disease but treating the non-disease.

But……

Is it really possible?

Indeed, on the basis of precision medical gene sequencing, it is theoretically possible to culture T cells in vitro.

but……

Second-generation sequencing technology uses high-throughput sequencing technology.

Chen Nan didn't understand the core content of precise sequencing before. If it were before today, he would definitely be as shocked as everyone else at the scene by the other party's theory.

After all, if Gilead really manages to intervene in tumor cells early, it could be a great thing.

Offstage!

Many people were a little moved at this time.

Even Guild President Drizzt fell into deep thought at this time.

Professor James Hacken looked solemn and said nothing. He was trying hard to think about the feasibility of this treatment.

The core of CAR-T cell therapy lies in multiple targets, allowing cultured T cells to recognize those tumor cells and carry out self-immunity.

The previous target was to target the nucleic acids of existing tumor cells.

but……

At this time, if they can really achieve early intervention, this will definitely be a great thing for tumors.

Under the stage, heated discussions arose one after another.

"If car-T cell therapy can really do this, it would be amazing!"

"Yes, allowing T cells to improve and successfully identify tumor cells and kill them can be said to strengthen the body's immune function, and it is even much less powerful than the effects of radiotherapy and chemotherapy."

"It's unbelievable that Gilead has such strength!"

"yes……"

In the audience, more and more experts began to discuss and think crazily.

When Joffrey saw this scene, he smiled inwardly and looked at Chen Nan not far away with a bit of mockery in his eyes.

It seems to be saying: Look? See? This is the real strength!

soon!

Someone stood up and began to speak and ask questions: "Mr. Joffrey, at what stage is the current progress of this treatment?"

“How much feasibility analysis do you have?”

This person is a board member of the Cancer Society, and his question quickly attracted everyone's attention.

Seeing this, Joffrey smiled and said:

"Professor, our feasibility, at present, there should be no problem!"

"We have reached a cooperation agreement with NMPA sequencing company to cooperate on early prediction of tumor cell targets!"

"However, it is undeniable that this is an absolutely remarkable progress and a great creation in the history of cancer."

"Currently, our progress is only over 40%, but every day, our scientists are researching and innovating, and our progress is moving forward!"

When Joffrey said these words, the audience burst into applause that lasted for a long time.

No one hates a person who changes the times.

In this new drug launch, every publisher needs to face the doubts of experts in the audience to answer questions and express their opinions.

Likewise, this is also the meaning of this press conference.

After the director finished his speech, people in the audience quickly stood up.

"Mr. Joffrey, I have a question. The biggest problem with CAR-T cell therapy is that the human body cannot tolerate the improved T cells. When the immune response is enhanced, the body's wear and tear will also increase."
To be continued...